JohnMDenefrioMD

PubMed

• Dedication of this Issue to: William Wallace Scott, MD, PhD, DSc
  R. Gaunt, D.J. Merchant, P. Frost, R. Wiltrout, Z. Maciorowski, N.R. Rose, S.A. Shain, B. McCullough, M. Nitchuk, R.W. Boesel, N. Kadohama, Kirdani Ry, Avery A. Sandbe...> ;Oncology. 2004 Jul 1
• Studies on the Clinical Pharmacokinetics of Imidazopyrazole
  Larry M. Allen, Morgan Feely, John Denefrio> ;Journal of Clinical Pharmacology. 1980 May 6
• Phase I clinical trial of weekly iv 2,3-dihydro-1H-imidazo[1,2-b]pyrazole (IMPY).
  Vogel, C. L., Denefrio, J. M., Padgett, D. C., Silverman, M. A.> ;Cancer Treat Rep. 1980 Oct 01
• Response to maytansine in a patient with malignant thymoma.
  Jaffrey, I. S., Denefrio, J. M., Chahinian, P.> ;Cancer Treat Rep. 1980 Jan
• Phase II study of cyclophosphamide and cytarabine in the treatment of metastatic adenocarcinoma of the colon and rectum.
  Denefrio, J. M., Kaplan, R. S., Eisenberger, M. A., Lessner, H. E.> ;Cancer Treat Rep. 1981 Jan 01
• Combination chemotherapy with bleomycin and hydroxyurea in the treatment of advanced head and neck cancer.
  Eisenberger, M. A., Denefrio, J., Silverman, M., Lessner, H. E.> ;Cancer Treat Rep. 1982 Jun
• Comparative serum theophylline levels following the oral administration of elixophyllin and somophyllino-O, a new preparation of aminophylline.
  Sherter, C., Denefrio, J.> ;Curr Ther Res Clin Exp. 1974 Mar 01
• 28 citations
  Chemotherapy of the Transplantable Adenocarcinoma (R-3327) of the Copenhagen Rat
  N.L. Block, F. Camuzzi, J. Denefrio, M. Troner, Alice J. Claflin, B. Stover, Victor A. Politano> ;Oncology. 1977 Jan 1
• Phase II study of mitomycin C and vinblastine in women with advanced breast cancer refractory to standard cytotoxic therapy.
  Denefrio, J. M., East, D. R., Troner, M. B., Vogel, C. L.> ;Cancer Treat Rep. 1978 Dec
• Phae II study of hexamethylmelamine in women with advanced breast cancer refractory to standard cytotoxic therapy.
  Denefrio, J. M., Vogel, C. L.> ;Cancer Treat Rep. 1978 Jan
• Join now to see all